Evidence map›Paper›PMID 39572748›Full record

ArticleNature medicine2025

Author Correction: Subclassification of obesity for precision prediction of cardiometabolic diseases.

Daniel E Coral, Femke Smit, Ali Farzaneh, Alexander Gieswinkel, Juan Fernandez Tajes, Thomas Sparsø, Carl Delfin, Pierre Bauvin, Kan Wang, Marinella Temprosa and 19 more

Abstract readPublished Erratum
In one paragraph

Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Daniel E Coral *Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Science, Lund University, Helsingborg, Sweden. daniel.coral@med.lu.se.ORCID http://orcid.org/0000-0002-8809-4544
Femke Smit *Maastricht Centre for Systems Biology (MaCSBio), Maastricht University, Maastricht, The Netherlands. f.smit@maastrichtuniversity.nl.ORCID http://orcid.org/0000-0001-7061-1913
Ali Farzaneh *Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0009-0005-4496-2863
Alexander GieswinkelPreventive Cardiology and Preventive Medicine, Center for Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.ORCID http://orcid.org/0009-0004-7014-5624
Juan Fernandez TajesGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Science, Lund University, Helsingborg, Sweden.
Thomas SparsøDepartment of Pharmacometrics, Novo Nordisk A/S, Søborg, Denmark.
Carl DelfinDepartment of Pharmacometrics, Novo Nordisk A/S, Søborg, Denmark.
Pierre BauvinUniversité de Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1190-EGID, Lille, France.
Kan WangDepartment of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-0294-7594
Marinella TemprosaBiostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Rockville, MD, USA.ORCID http://orcid.org/0000-0002-9976-745X
Diederik De CockBiostatistics and Medical Informatics Research Group, Department of Public Health, Vrije Universiteit Brussel, Brussels, Belgium.
Jordi BlanchNutrition, Eumetabolism and Health Group, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), Girona, Spain.
José Manuel Fernández-RealNutrition, Eumetabolism and Health Group, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), Girona, Spain.ORCID http://orcid.org/0000-0002-7442-9323
Rafael RamosNutrition, Eumetabolism and Health Group, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), Girona, Spain.
M Kamran IkramDepartments of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0173-9571
Maria F GomezDiabetic Complications Unit, Lund University Diabetes Centre, Department of Clinical Science, Lund University, Malmö, Sweden.ORCID http://orcid.org/0000-0001-6210-3142
Maryam KavousiDepartments of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-5976-6519
Marina Panova-NoevaTranslational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
Philipp S WildPreventive Cardiology and Preventive Medicine, Center for Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0003-4413-9752
Carla van der KallenSchool for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.ORCID http://orcid.org/0000-0003-1468-8793
Michiel AdriaensMaastricht Centre for Systems Biology (MaCSBio), Maastricht University, Maastricht, The Netherlands.
Marleen van GreevenbroekSchool for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.ORCID http://orcid.org/0000-0002-2989-1631
Ilja ArtsMaastricht Centre for Systems Biology (MaCSBio), Maastricht University, Maastricht, The Netherlands.ORCID http://orcid.org/0000-0001-6462-6692
Carel Le RouxDiabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin, Ireland.ORCID http://orcid.org/0000-0001-5521-5445
Fariba AhmadizarData Science and Biostatistics Department, Julius Global Health, University Medical Center Utrecht, Utrecht, The Netherlands.
Timothy M FraylingGenetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, UK.ORCID http://orcid.org/0000-0001-8362-2603
Giuseppe N GiordanoGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Science, Lund University, Helsingborg, Sweden.
Ewan R PearsonPopulation Health and Genomics, University of Dundee, Dundee, UK.ORCID http://orcid.org/0000-0001-9237-8585
Paul W FranksGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Science, Lund University, Helsingborg, Sweden. paul.franks@med.lu.se.ORCID http://orcid.org/0000-0002-0520-7604

Funding

European Commission (EC) 681742Innovative Medicines Initiative (IMI) 875534Stiftelsen för Strategisk Forskning (Swedish Foundation for Strategic Research) LUDC-IRC 15-0067Vetenskapsrådet (Swedish Research Council) 2019-01348
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39572748
PMCPMC11835709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.